Azenta Raised to Overweight From Equal-Weight by Stephens & Co.
Azenta Analyst Ratings
Stephens Upgrades Azenta(AZTA.US) to Buy Rating, Raises Target Price to $60
Azenta Is Maintained at Buy by Needham
Azenta Analyst Ratings
Needham Maintains Azenta(AZTA.US) With Buy Rating, Cuts Target Price to $55
Azenta Is Maintained at In-Line by Evercore ISI Group
Azenta Analyst Ratings
Evercore Maintains Azenta(AZTA.US) With Hold Rating, Cuts Target Price to $50
Azenta Analyst Ratings
Buy Rating Justified by Azenta's Strong Q3 Performance and Growth Potential
Azenta Analyst Ratings
Azenta Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Green Thumb Industries (OtherGTBIF) and Azenta (AZTA)
Azenta Analyst Ratings
Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)
Azenta Analyst Ratings
Buy Rating Affirmed for Azenta: A Promising Future Backed by Strategic Growth Plans
Azenta Analyst Ratings